This site is intended for healthcare professionals
Drug news

Phase III programme of GSK 573719 plus vilanterol (Glaxo Smith Kline/Theravance) for COPD completed

Read time: 1 mins
Last updated:26th Aug 2012
Published:26th Aug 2012
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest